Breast Cancer Detection and Localizing the Mass Area Using Deep Learning

Breast cancer presents a substantial health obstacle since it is the most widespread invasive cancer and the second most common cause of death in women. Prompt identification is essential for effective intervention, rendering breast cancer screening a critical component of healthcare. Although mammography is frequently employed for screening purposes, the manual diagnosis performed by pathologists can be laborious and susceptible to mistakes. Regrettably, the majority of research prioritizes mass classification over mass localization, resulting in an uneven distribution of attention. In response to this problem, we suggest a groundbreaking approach that seeks to identify and pinpoint cancers in breast mammography pictures. This will allow medical experts to identify tumors more quickly and with greater precision. This paper presents a complex deep convolutional neural network design that incorporates advanced deep learning techniques such as U-Net and YOLO. The objective is to enable automatic detection and localization of breast lesions in mammography pictures. To assess the effectiveness of our model, we carried out a thorough review that included a range of performance criteria. We specifically evaluated the accuracy, precision, recall, F1-score, ROC curve, and R-squared error using the publicly available MIAS dataset. Our model performed exceptionally well, with an accuracy rate of 93.0% and an AUC (area under the curve) of 98.6% for the detection job. Moreover, for the localization task, our model achieved a remarkably high R-squared value of 97%. These findings highlight that deep learning can boost the efficiency and accuracy of diagnosing breast cancer. The automation of breast lesion detection and classification offered by our proposed method bears substantial benefits. By alleviating the workload burden on pathologists, it facilitates expedited and accurate breast cancer screening processes. As a result, the proposed approach holds promise for improving healthcare outcomes and bolstering the overall effectiveness of breast cancer detection and diagnosis.